| scholarly article | Q13442814 |
| P356 | DOI | 10.1159/000481684 |
| P698 | PubMed publication ID | 29141241 |
| P2093 | author name string | Harald Arnesen | |
| Sigrun Halvorsen | |||
| Ingebjørg Seljeflot | |||
| Ellen Bøhmer | |||
| Trine Baur Opstad | |||
| P2860 | cites work | Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevat | Q43277765 |
| Plasma active matrix metalloproteinase 9 and indices of diastolic function in patients with preserved systolic function | Q44194690 | ||
| Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblasts | Q45223757 | ||
| Troponin T concentration 3 days after acute ST-elevation myocardial infarction predicts infarct size and cardiac function at 3 months | Q47195595 | ||
| Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes | Q47671940 | ||
| Inflammatory and thrombotic markers in patients with ST-elevation myocardial infarction treated with thrombolysis and early PCI: a NORDISTEMI substudy. | Q51356609 | ||
| Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction. | Q51810447 | ||
| The Long-Term Influence of Tissue Inhibitor of Matrix Metalloproteinase-1 in Patients with Mild to Moderate Coronary Artery Lesions in a Chinese Population: A 7-Year Follow-Up Study. | Q53382759 | ||
| Upstream regulation of matrix metalloproteinase by EMMPRIN; extracellular matrix metalloproteinase inducer in advanced atherosclerotic plaque | Q58492191 | ||
| Tissue inhibitors of metalloproteinases: evolution, structure and function | Q28138083 | ||
| Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction | Q34138706 | ||
| The MMP-9 -1562 C/T polymorphism in the presence of metabolic syndrome increases the risk of clinical events in patients with coronary artery disease | Q34142412 | ||
| Interleukin-18 induces EMMPRIN expression in primary cardiomyocytes via JNK/Sp1 signaling and MMP-9 in part via EMMPRIN and through AP-1 and NF-kappaB activation | Q34212169 | ||
| Usefulness of circulating biomarkers for the prediction of left ventricular remodeling after myocardial infarction | Q34223911 | ||
| The influence of autologous bone marrow stem cell transplantation on matrix metalloproteinases in patients treated for acute ST-elevation myocardial infarction | Q34257083 | ||
| Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques | Q34327535 | ||
| The inflammatory response in myocardial infarction | Q34463456 | ||
| TIMPs as multifacial proteins | Q35703646 | ||
| Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window | Q36344710 | ||
| Biomarkers of atherosclerotic plaque instability and rupture | Q36643429 | ||
| Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction | Q37527656 | ||
| Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications | Q37850831 | ||
| Heart failure and role of circulating MMP-2 and MMP-9. | Q39235190 | ||
| Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease | Q40596987 | ||
| Left ventricular function in acute myocardial infarction treated with thrombolysis followed by early versus late invasive strategy | Q42990917 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 17-24 | |
| P577 | publication date | 2017-11-16 | |
| P1433 | published in | Cardiology | Q2404578 |
| P1476 | title | MMP-9 and Its Regulators TIMP-1 and EMMPRIN in Patients with Acute ST-Elevation Myocardial Infarction: A NORDISTEMI Substudy | |
| P478 | volume | 139 |
| Q92341061 | Effects of exercise training on markers of adipose tissue remodeling in patients with coronary artery disease and type 2 diabetes mellitus: sub study of the randomized controlled EXCADI trial |
| Q57035768 | Nanomedicine for gene delivery for the treatment of cardiovascular diseases |
| Q94552355 | Prediction of the Network Pharmacology-Based Mechanism for Attenuation of Atherosclerosis in Apolipoprotein E Knockout Mice by Panax notoginseng Saponins |
Search more.